Substrate Design Enables Heterobifunctional, Dual “Click” Antibody Modification via Microbial Transglutaminase
- 13 August 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 30 (9) , 2452-2457
Abstract
Site-specific modification of native antibodies has proven advantageous, as it enhances the properties of antibody-based bioconjugates without the need to manipulate the genetic code. However, native antibody modification is typically limited to strategies that introduce a single functional handle. In this work, we addressed this limitation by designing heterobifunctional substrates for microbial transglutaminase (MTG) that contain both azide and methyltetrazine “click” handles. Structure-conjugation relationships for these substrates were evaluated using the Her2-targeted antibody trastuzumab. Förster resonance energy transfer (FRET) was used to demonstrate that these chemical handles are mutually orthogonal. This orthogonality was leveraged for the one-pot synthesis of a bifunctional antibody-drug conjugate (ADC). This ADC, containing a maytansine-derived payload and a hydrophobicity-masking polyethylene glycol (PEG) side chain, demonstrated potent in vitro activity in SKOV3 cells. These studies establish the dual “click” approach as a powerful technique in the toolbox for native antibody modification.Keywords
Funding Information
- Division of Chemistry (CHE-1531632)
- Division of Graduate Education (DGE-1650441)
- Cornell University
- RF Smith School of Chemical and Biomolecular Engineering
This publication has 56 references indexed in Scilit:
- Protein-retention expansion microscopy of cells and tissues labeled using standard fluorescent proteins and antibodiesNature Biotechnology, 2016
- Development of Novel Quaternary Ammonium Linkers for Antibody–Drug ConjugatesMolecular Cancer Therapeutics, 2016
- A covalent and cleavable antibody-DNA conjugation strategy for sensitive protein detection via immuno-PCRScientific Reports, 2016
- Novel antibody–antibiotic conjugate eliminates intracellular S. aureusNature, 2015
- Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic indexNature Biotechnology, 2015
- In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's diseaseNature Medicine, 2014
- Enzyme-Mediated Methodology for the Site-Specific Radiolabeling of Antibodies Based on Catalyst-Free Click ChemistryBioconjugate Chemistry, 2013
- T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized MiceCell, 2008
- Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptorsNature Biotechnology, 2005
- A stable chemiluminescent-labelled antibody for immunological assaysNature, 1979